Analysis of comorbid factors that increase the COPD assessment test scores. - Wikidata - wikimedia - TriplyDB

Analysis of comorbid factors that increase the COPD assessment test scores.

Analysis of comorbid factors that increase the COPD assessment test scores.

http://www.wikidata.org/entity/Q37579517

about

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review COPD and its comorbidities: Impact, measurement and mechanisms Underrecognized comorbidities of chronic obstructive pulmonary disease Managing comorbidities in COPD Changes in exercise capacity, muscle strength, and health-related quality of life in esophageal cancer patients undergoing esophagectomy.Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease.COPD Assessment Test (CAT) score as a predictor of major depression among subjects with chronic obstructive pulmonary disease and mild hypoxemia: a case-control study.The effect of comorbidities on COPD assessment: a pilot study Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.The reasons for triple therapy in stable COPD patients in Japanese clinical practice.Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients.Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients.Clinical factors and comorbidities affecting the cost of hospital-treated COPD.The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.Impact of mild exacerbation on COPD symptoms in a Japanese cohort Prevalence, awareness, characteristics, and health outcomes associated with COPD at-risk status among adults in Japan.The Relationship of Bone Mineral Density in Men with Chronic Obstructive Pulmonary Disease Classified According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Combined Chronic Obstructive Pulmonary Disease (COPD) Assessment Sys Defining COPD-Related Comorbidities, 2004-2014.Czech multicenter research database of severe COPD.All-cause mortality in asthma. The importance of age, comorbidity, and socioeconomic status.Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort.Impact of cataract on health-related quality of life in a longitudinal Japanese chronic obstructive pulmonary cohort.Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population.Social isolation in individuals with chronic respiratory failure undergoing long-term oxygen therapy.Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD.Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.Physical frailty characteristics have a differential impact on symptoms as measured by the CAT score: an observational study.COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

P2860

Q24288655-692D68BC-4A4B-4A9C-8EC0-F0941531553A Q26786812-2695179E-E096-47EE-A218-933D9E1900C7 Q26800282-DC96E7DD-A1CD-47D2-9BD7-38F785902E30 Q27005858-889004D9-B8FD-427F-B99C-5B2AE71D7BA6 Q30827365-A410DEA8-DAF2-44E7-97C7-47D8BE5990E6 Q30992068-D1C9F177-D85B-4711-9900-15E218CD756A Q33766475-F6DB8BD3-D6C6-44EF-8106-C70409BD859C Q34875027-47F792B4-8BDA-4F4F-9E9E-6BA5116BB968 Q35142397-3E1922DE-1BC3-4905-9EB0-6392D87F6CD1 Q35683840-C22EC87E-4A57-4F14-801E-611A538B5C2A Q35703852-9528988A-4EEA-4945-80F1-AB378B90ED3B Q35884573-BF59B605-EA95-4795-8720-1486BB420CAA Q36344023-F5D6F288-C3AA-459A-98DB-2F989782E064 Q37485333-AB441557-6F37-4397-B790-FF997F571429 Q37571664-C41C8695-5E6B-45AA-ABEA-244B3BAD1AA2 Q38217416-A22D8E0D-76FA-42BF-A534-967AD0896117 Q38944856-B3D4C32B-4E64-4880-8336-CAFDB6158389 Q39646728-A2C3CFAA-E449-4F0A-967E-18A46573C8CF Q40399079-71A00D9B-34B8-4F30-89AE-EAB177FB89C3 Q41307834-C8D217C3-9DAA-4DF0-A3DA-5BE3DCA77B5E Q41443181-10DB27E7-1A7F-4AEC-9AE9-16DCB6020237 Q43010454-5A743FA8-0A5E-497C-B0B3-99A95B3FE526 Q43111099-FDAA29B6-9D6F-4ABC-AF68-E65D874F3043 Q47131947-74E4CD82-8056-4E1C-ACE7-FF35251AA782 Q47323274-E875FE24-67CE-4B19-924B-4F44801FF53B Q47646743-D2B7A733-191B-4F9C-925F-FDB2C01FA048 Q48207923-1DE5E3DE-3B97-490B-8A98-6BAB3DEFF999 Q50613948-E9C65220-9680-4979-AC11-87686FFC6A2A Q52347115-26578A38-576F-4F05-9C01-2E19EF1D2D1D Q55387022-56DAA0E5-3DA6-4BD0-8901-4B40C164F995 Q55717230-212F4B0D-96DA-4851-9604-912F8074BBAB Q58698628-97D15A05-0233-4D1C-83E3-F90300510B0E

P2860

Analysis of comorbid factors that increase the COPD assessment test scores.

http://www.wikidata.org/entity/Q37579517

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analysis of comorbid factors that increase the COPD assessment test scores.

@en

Analysis of comorbid factors that increase the COPD assessment test scores.

@nl

type

label

Analysis of comorbid factors that increase the COPD assessment test scores.

@en

Analysis of comorbid factors that increase the COPD assessment test scores.

@nl

prefLabel

Analysis of comorbid factors that increase the COPD assessment test scores.

@en

Analysis of comorbid factors that increase the COPD assessment test scores.

@nl

P1433

Q37579517-F8A586AF-1C35-4731-85E2-091DC002B50F

P1476

Q37579517-6A5CE9CC-6ABF-4D5F-8B77-05C8C9B7AF2B

P2093

Q37579517-045D3301-E1FF-473C-8D7B-BE6D712E6E1D

Q37579517-0CC631F9-3695-45D9-BC5F-FC19A35BE996

Q37579517-13B9A2C5-FAB1-4AEE-B18F-A99AD19C4E25

Q37579517-178BC805-BB00-4F83-8183-F493A5E46449

Q37579517-29BBD235-682E-41AD-A87F-51C91465C04B

Q37579517-2AF6B7B3-AF1F-4082-AB51-5C9E51B86A9E

Q37579517-3762F29D-693A-4B58-A8A6-B7B6E4C8960C

Q37579517-816FD808-7800-4C68-91AC-37B03781F75A

Q37579517-890E58D7-40FB-4E0D-A14B-A9B12C817636

Q37579517-89A9288D-4667-4BDE-BE55-1884A3E77F17

P2860

Q37579517-1612A1C3-E348-44D2-B28A-5342E08D631F

Q37579517-18ED15C1-6D1F-4CF6-A11D-8A10AFE86C3A

Q37579517-1E4564A0-1855-457C-AA80-BBAACBA515CD

Q37579517-1F5B25E8-46B1-4A30-A1AF-4B671FDB4466

Q37579517-283D6950-E671-4D79-BF81-445B27656074

Q37579517-2FAE4E2A-1002-49BB-9036-433CE8C0A5D9

Q37579517-36F5E377-68F2-44C3-BC73-DA11FE837A04

Q37579517-453763E8-13BD-438D-830A-C3D8D56BD93B

Q37579517-4DA8D8FB-E10F-42CF-A2AD-3D7A9C7C50C1

Q37579517-59643D13-58D7-4405-A6E7-7B3AC8887965

P2888

Q37579517-C0E44601-8A8B-4625-B45D-5A28DD95D434

P304

Q37579517-1BD124BF-6BB1-4210-B6A4-7DEA5056EED4

P31

Q37579517-628C3C07-7827-48A1-B185-B73BD6411B18

P356

Q37579517-7760120C-B587-443E-85B4-9C2E153B1B0E

P478

Q37579517-05317189-F536-4B09-8672-E8D76F583EAA

P577

Q37579517-EA721B22-EF14-456D-965D-4EC23E15AB66

P5875

Q37579517-ABCBC34D-E015-4B41-B9F1-0C67C2F8BD71

P6179

Q37579517-0E3EFC85-737F-4E63-8F97-4CE05D4F624A

P698

Q37579517-583E141D-6355-4D7F-94EE-8B9A0395565D

P932

Q37579517-002D460D-47FB-4BEC-9908-0F992A905536

P356

1465-9921-15-13

P1433

Respiratory Research

P1476

Analysis of comorbid factors that increase the COPD assessment test scores.

@en

P2093

Fumio Sakamaki

http://www.w3.org/2001/XMLSchema#string

Hidefumi Koh

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Nakamura

http://www.w3.org/2001/XMLSchema#string

Keio COPD Comorbidity Research (K-CCR) Group

http://www.w3.org/2001/XMLSchema#string

Keishi Tsuduki

http://www.w3.org/2001/XMLSchema#string

Koichi Sayama

http://www.w3.org/2001/XMLSchema#string

Koichiro Asano

http://www.w3.org/2001/XMLSchema#string

Mamoru Sasaki

http://www.w3.org/2001/XMLSchema#string

Masaki Miyazaki

http://www.w3.org/2001/XMLSchema#string

Mizuha Haraguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

The hospital anxiety and depression scale

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

Standardization of Spirometry, 1994 Update. American Thoracic Society

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.

Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation.

COPD and osteoporosis.

Validity of the COPD assessment test translated into local languages for Asian patients.

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.

P2888

1465-9921-15-13

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-15-13

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260119446

http://www.w3.org/2001/XMLSchema#string

P6179

1037980314

http://www.w3.org/2001/XMLSchema#string

P698

24502760

http://www.w3.org/2001/XMLSchema#string

P932

3922022

http://www.w3.org/2001/XMLSchema#string